Skip to main content

Jonathan Goldman

Analyst

Scotiabank

Equibles does not estimate personal net worth.

About Jonathan Goldman

Jonathan Goldman is recorded as Analyst at Scotiabank. Jonathan Goldman was last confirmed as Board Member at Avalo Therapeutics, Inc. (AVTX) in a filing dated May 1, 2025. Avalo Therapeutics, Inc. reported in an 8-K filed March 28, 2024 that Jonathan Goldman was appointed director, effective March 27, 2024. Jonathan Goldman has spoken on 13 earnings calls across 6 companies, most recently for Stantec Inc on August 13, 2026. Those appearances were for Stantec Inc (STN), Boyd Group Services Inc. (BGSI), Magna International Inc (MGA), ATS Corp (ATS), Toromont Industries Ltd. (TMTNY) and 1 other company. The companies whose calls Jonathan Goldman spoke on are classified in the Industrials and Consumer Cyclical sectors.

“Pursuant to the Merger Agreement, Jonathan Goldman was appointed to the Company's Board of Directors (the "Board") effective on the closing of the Merger.”
Avalo Therapeutics, Inc. Form 8-K, filed March 28, 2024 · Read the filing

Jonathan Goldman on recent calls

“Most of them have been asked already, but maybe, Gord, just one for you philosophically. How are you thinking about the pace of consolidation in the ENC space? Maybe you can just update us on how fragmented it is today.”
Analyst — Scotiabank, Q2 2026 Webcast and Conference Call ·
“Was there anything in the quarter that you would classify as one time or a headwind, particularly on a year over year basis in terms of capturing same store sales volume?”
Analyst — Scotia Bank, Second Quarter Earnings Announcement ·
“Maybe, Phil, just a couple to start off on the margins. Is it possible to tease out the basis point impact of operational excellence and the higher commodity costs in the quarter?”
Analyst — Scotiabank, Q2 2026 Magna International Inc. Earnings Webcast ·
“Maybe just a housekeeping one for you, John. Construction product support, did you say up six or down six? And the product support margin, did you say similar year-on-year?”
Analyst — Scotiabank, Toromont Industries Ltd. – Second Quarter 2026 Results ·
“I know it's a small item, but the full-year revenue guidepost for modest growth, is that gross or net, the transportation headwind?”
Analyst — Scotiabank, Q4 Fiscal 2026 Earnings Conference Call ·

Affiliation history

  • Scotiabank

    Analyst

    Transcript header (unverified)

    Current
  • Avalo Therapeutics, Inc. (AVTX)

    Board Member

    Proxy statement

    2024-01-01–2025-05-01

    Last confirmed by a filing; no departure on record

Company network

NFI Group Inc.

Auto Manufacturers · Consumer Cyclical

1 appearance Latest appearance 2026-05-08

Recent activity